MEDIFAST INC
For the period ended Apr 28, 2025. Filed Apr 28, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Apr 28, 2025 · Filed Apr 28, 2025
Use the contents to explore the available documents and sections.
MED$12.81+0.6%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Outlook
Outlook
The company expects second quarter 2025 revenue to be in the range of $85 million to $105 million and second quarter 2025 loss per share to be in the range of $0.00 to $0.55. The loss per share range excludes any gains or losses from changes in the market price of the company’s LifeMD common stock investment.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.